NasdaqGS - Delayed Quote USD
Amylyx Pharmaceuticals, Inc. (AMLX)
At close: October 21 at 4:00 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 609,171 | 9 |
Sales | 67,784 | 5 |
Net Shares Purchased (Sold) | 541,387 | 14 |
Total Insider Shares Held | 9.77M | -- |
% Net Shares Purchased (Sold) | 5.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
BEDROSIAN CAMILLE L Officer | Sale at price 3.20 per share. | Direct | 36,559 | Sep 30, 2024 |
COHEN JOSHUA BARRY Chief Executive Officer | Sale at price 3.20 per share. | Direct | 59,414 | Sep 30, 2024 |
KLEE JUSTIN B Chief Executive Officer | Sale at price 3.20 per share. | Direct | 59,429 | Sep 30, 2024 |
MAZZARIELLO GINA Officer | Sale at price 3.20 per share. | Direct | 27,840 | Sep 30, 2024 |
COHEN JOSHUA BARRY Chief Executive Officer | Conversion of Exercise of derivative security at price 1.57 per share. | Direct | 2,915 | Sep 23, 2024 |
COHEN JOSHUA BARRY Chief Executive Officer | Conversion of Exercise of derivative security at price 1.57 per share. | Direct | 54,085 | Sep 12, 2024 |
FRATES JAMES MATTHEW Chief Financial Officer | Purchase at price 2.53 per share. | Direct | 101,368 | Sep 12, 2024 |
FIRESTONE KAREN M. Director | Purchase at price 2.13 per share. | Direct | 106,590 | Sep 5, 2024 |
MILNE GEORGE MCLEAN JR Director | Purchase at price 2.20 per share. | Direct | 219,800 | Sep 3, 2024 |
MAZZARIELLO GINA Officer | Sale at price 1.88 per share. | Direct | 19,654 | May 15, 2024 |
QUIMI DAPHNE Director | Purchase at price 1.88 - 1.89 per share. | Direct | 9,436 | May 15, 2024 |
KLEE JUSTIN B Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 16, 2024 |
MAZZARIELLO GINA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 16, 2024 |
BEDROSIAN CAMILLE L Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 16, 2024 |
FRATES JAMES MATTHEW Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 16, 2024 |
COHEN JOSHUA BARRY Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 16, 2024 |
FRATES JAMES MATTHEW Chief Financial Officer | Sale at price 18.73 per share. | Direct | 33,560 | Mar 5, 2024 |
COHEN JOSHUA BARRY Chief Executive Officer | Sale at price 18.73 per share. | Direct | 77,440 | Mar 5, 2024 |
KLEE JUSTIN B Chief Executive Officer | Sale at price 18.73 per share. | Direct | 77,440 | Mar 5, 2024 |
MAZZARIELLO GINA Officer | Sale at price 18.73 per share. | Direct | 28,841 | Mar 5, 2024 |
KLEE JUSTIN B Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 26, 2024 |
MAZZARIELLO GINA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 26, 2024 |
FRATES JAMES MATTHEW Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 26, 2024 |
COHEN JOSHUA BARRY Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 26, 2024 |
MAZZARIELLO GINA Officer | Sale at price 18.76 per share. | Direct | 53,231 | Feb 23, 2024 |
MILNE GEORGE MCLEAN JR Director | Stock Gift at price 0.00 per share. | Direct | 0 | Jan 25, 2024 |
MILNE GEORGE MCLEAN JR Director | Stock Gift at price 0.00 per share. | Direct | 0 | Jan 16, 2024 |
YERAMIAN PATRICK D Officer | Sale at price 16.33 per share. | Direct | 45,915 | Jan 9, 2024 |
FRATES JAMES MATTHEW Chief Financial Officer | Sale at price 16.33 per share. | Direct | 44,347 | Jan 9, 2024 |
COHEN JOSHUA BARRY Chief Executive Officer | Sale at price 16.33 per share. | Direct | 95,372 | Jan 9, 2024 |
KLEE JUSTIN B Chief Executive Officer | Sale at price 16.33 per share. | Direct | 95,372 | Jan 9, 2024 |
OLINGER MARGARET Officer | Conversion of Exercise of derivative security at price 0.37 per share. | Direct | 9,250 | Dec 27, 2023 |
FIRESTONE KAREN M. Director | Purchase at price 14.97 per share. | Direct | 59,880 | Dec 15, 2023 |
BEDROSIAN CAMILLE L Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 27, 2023 |
COHEN JOSHUA BARRY Chief Executive Officer | Conversion of Exercise of derivative security at price 1.57 per share. | Direct | 100,000 | Nov 16, 2023 |
FRATES JAMES MATTHEW Chief Financial Officer | Conversion of Exercise of derivative security at price 6.88 per share. | Direct | 124,975 | Aug 23, 2023 |
FRATES JAMES MATTHEW Chief Financial Officer | Conversion of Exercise of derivative security at price 6.88 per share. | Direct | 124,975 | Aug 23, 2023 |
MAZZARIELLO GINA Officer | Sale at price 20.88 per share. | Direct | 128,686 | Aug 15, 2023 |
OLINGER MARGARET Officer | Conversion of Exercise of derivative security at price 0.37 per share. | Direct | 7,400 | Jul 12, 2023 |
OLINGER MARGARET Officer | Stock Gift at price 0.00 per share. | Direct | 0 | May 22, 2023 |
MAZZARIELLO GINA Officer | Stock Gift at price 0.00 per share. | Direct | 0 | May 17, 2023 |
FRATES JAMES MATTHEW Chief Financial Officer | Conversion of Exercise of derivative security at price 6.88 per share. | Direct | 223,600 | May 16, 2023 |
FRATES JAMES MATTHEW Chief Financial Officer | Sale at price 26.93 - 27.60 per share. | Direct | 875,451 | May 16, 2023 |
YERAMIAN PATRICK D Officer | Conversion of Exercise of derivative security at price 0.37 - 6.88 per share. | Direct | 67,991 | May 15, 2023 |
YERAMIAN PATRICK D Officer | Sale at price 29.03 per share. | Direct | 347,358 | May 15, 2023 |
YERAMIAN PATRICK D Officer | Conversion of Exercise of derivative security at price 0.37 - 6.88 per share. | Direct | 49,058 | Apr 17, 2023 |
YERAMIAN PATRICK D Officer | Sale at price 30.53 - 30.94 per share. | Direct | 1,513,942 | Apr 17, 2023 |
YERAMIAN PATRICK D Officer | Conversion of Exercise of derivative security at price 0.33 - 6.88 per share. | Direct | 127,262 | Mar 16, 2023 |
FRATES JAMES MATTHEW Chief Financial Officer | Conversion of Exercise of derivative security at price 6.88 per share. | Direct | 223,600 | Mar 16, 2023 |
MILNE GEORGE MCLEAN JR Director | Sale at price 31.86 - 32.45 per share. | Direct | 1,116,072 | Mar 16, 2023 |
Related Tickers
VTYX Ventyx Biosciences, Inc.
2.3900
-5.91%
MGTX MeiraGTx Holdings plc
5.99
-2.44%
URGN UroGen Pharma Ltd.
12.52
-1.65%
JSPR Jasper Therapeutics, Inc.
19.90
-0.70%
PRQR ProQR Therapeutics N.V.
4.0500
-6.47%
OCUL Ocular Therapeutix, Inc.
11.37
+0.35%
CRVS Corvus Pharmaceuticals, Inc.
7.56
+4.85%
SEEL Seelos Therapeutics, Inc.
1.1300
+11.88%
APLS Apellis Pharmaceuticals, Inc.
26.88
-4.00%
ATYR aTyr Pharma, Inc.
3.2600
+9.03%